These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25840413)

  • 21. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.
    Haase A; Glienke W; Engels L; Göhring G; Esser R; Arseniev L; Martin U
    Stem Cell Res; 2019 Mar; 35():101394. PubMed ID: 30772682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
    Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
    Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells.
    Bharathan SP; Manian KV; Aalam SM; Palani D; Deshpande PA; Pratheesh MD; Srivastava A; Velayudhan SR
    Biol Open; 2017 Jan; 6(1):100-108. PubMed ID: 28089995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins.
    Shamis Y; Hewitt KJ; Bear SE; Alt-Holland A; Qari H; Margvelashvilli M; Knight EB; Smith A; Garlick JA
    In Vitro Cell Dev Biol Anim; 2012 Feb; 48(2):112-22. PubMed ID: 22259014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells.
    Kondo Y; Toyoda T; Ito R; Funato M; Hosokawa Y; Matsui S; Sudo T; Nakamura M; Okada C; Zhuang X; Watanabe A; Ohta A; Inagaki N; Osafune K
    Diabetologia; 2017 Aug; 60(8):1454-1466. PubMed ID: 28534195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
    Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
    Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers.
    Fujitani N; Furukawa J; Araki K; Fujioka T; Takegawa Y; Piao J; Nishioka T; Tamura T; Nikaido T; Ito M; Nakamura Y; Shinohara Y
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2105-10. PubMed ID: 23345451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix-assisted laser desorption/ionization imaging mass spectrometry reveals changes of phospholipid distribution in induced pluripotent stem cell colony differentiation.
    Shimizu Y; Satou M; Hayashi K; Nakamura Y; Fujimaki M; Horibata Y; Ando H; Watanabe T; Shiobara T; Chibana K; Takemasa A; Sugimoto H; Anzai N; Ishii Y
    Anal Bioanal Chem; 2017 Feb; 409(4):1007-1016. PubMed ID: 27815610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for efficiently generating neurospheres from human-induced pluripotent stem cells using microsphere arrays.
    Shofuda T; Fukusumi H; Kanematsu D; Yamamoto A; Yamasaki M; Arita N; Kanemura Y
    Neuroreport; 2013 Jan; 24(2):84-90. PubMed ID: 23238165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells.
    Ohashi F; Miyagawa S; Yasuda S; Miura T; Kuroda T; Itoh M; Kawaji H; Ito E; Yoshida S; Saito A; Sameshima T; Kawai J; Sawa Y; Sato Y
    Sci Rep; 2019 Mar; 9(1):4638. PubMed ID: 30874579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.
    Barone A; Säljö K; Benktander J; Blomqvist M; Månsson JE; Johansson BR; Mölne J; Aspegren A; Björquist P; Breimer ME; Teneberg S
    J Biol Chem; 2014 Jul; 289(27):18846-59. PubMed ID: 24841197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic signature of human embryonic stem cells.
    Baharvand H; Hajheidari M; Ashtiani SK; Salekdeh GH
    Proteomics; 2006 Jun; 6(12):3544-9. PubMed ID: 16758447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells.
    Parrotta EI; Scalise S; Taverna D; De Angelis MT; Sarro G; Gaspari M; Santamaria G; Cuda G
    J Cell Mol Med; 2019 Aug; 23(8):5440-5453. PubMed ID: 31237115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.
    Zimmerlin L; Park TS; Huo JS; Verma K; Pather SR; Talbot CC; Agarwal J; Steppan D; Zhang YW; Considine M; Guo H; Zhong X; Gutierrez C; Cope L; Canto-Soler MV; Friedman AD; Baylin SB; Zambidis ET
    Development; 2016 Dec; 143(23):4368-4380. PubMed ID: 27660325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors.
    Ishikawa T; Kobayashi M; Yanagi S; Kato C; Takashima R; Kobayashi E; Hagiwara K; Ochiya T
    PLoS One; 2015; 10(4):e0123193. PubMed ID: 25875613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
    Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
    J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.